Arena Sdk CVE-2026-9169

Windows systems running LUCID Vision Labs Arena SDK 1.0.80.49 are exposed to local privilege escalation attacks that could compromise SDK operations and escalate to system-level control. Organizations deploying this SDK for industrial imaging or automation risk operational disruption and unauthorized access to connected systems or data. A vendor patch is not currently available, requiring immediate compensating controls.

Within 24 hours, inventory all systems running LUCID Vision Labs Arena SDK 1.0.80.49 and restrict the Windows PATH environment variable to exclude user-writable directories; deploy application whitelisting (e.g., AppLocker or Windows Defender Application Control) to restrict DLL execution to approved locations. Within 7 days, implement file creation and modification monitoring on common PATH directories and audit local user privileges on affected systems, revoking unnecessary elevated access where operationally possible. Within 30 days, contact LUCID Vision Labs for patched SDK availability and establish a formal upgrade plan; if no patch timeline is provided, escalate the vendor requirement and develop alternative compensating control standards.

No vendor-released patch identified at time of analysis. Interim mitigations: (1) Restrict PATH environment variable to exclude user-writable directories (temp folders, user profile paths); (2) Implement application whitelisting (AppLocker, WDAC) to restrict DLL loading to approved system and application directories; (3) Run SDK processes under dedicated low-privilege service accounts rather than user logon sessions; (4) Enable file creation and modification monitoring on system paths and temporary directories for detection of unauthorized DLLs; (5) Disable local RunAs and privilege elevation capabilities for the SDK application where operationally feasible; (6) Isolate affected systems on dedicated network segments if they access sensitive data or connect to critical operational infrastructure.